Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidar Sharafi

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Addiction (Abingdon, England)|March 15, 2026
A call for action: Closing the evidence gap in management of stimulant-induced psychosisAnne Bouthillier, Heidar Sharafi, Adam Bisaga, et al.
Systematic Reviews|February 8, 2026
COmprehensive Meta-analysis and meta-regression of Psychiatric disorders in people with Amphetamine-type Stimulant use disorder Study (COMPASS): a protocol for a pilot study, a systematic review and a meta-analysis seriesAnne-Marie Bissonnette, Heidar Sharafi, Florian Alatorre, et al.
Hepatitis Monthly|November 25, 2014
The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control StudyHeidar Sharafi, Seyed Moayed Alavian, Bita Behnava, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 21, 2015
Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013Maryam Keshvari, Heidar Sharafi, Seyed Moayed Alavian, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|December 2, 2016
The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis CMaryam Keshvari, Seyed Moayed Alavian, Bita Behnava, et al.
Hepatitis Monthly|January 27, 2017
Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic ReviewKhashayar Hesamizadeh, Seyed Moayed Alavian, Azar Najafi Tireh Shabankareh, et al.
Pathogens (Basel, Switzerland)|April 28, 2023
Trends in the Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Iranian Patients with Hereditary Bleeding DisordersAzar Gharoonpour, Saeideh Maleki, Hamid Sharifi, et al.
Hepatitis Monthly|April 19, 2014
Interferon alpha-2b therapy in chronic hepatitis deltaMaryam Keshvari, Seyed Moayed Alavian, Heidar Sharafi, et al.
World Journal of Gastroenterology|August 14, 2015
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patientsArghavan Haj-Sheykholeslami, Maryam Keshvari, Heidar Sharafi, et al.
Hepatitis Monthly|June 9, 2016
Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting AntiviralsKhashayar Hesamizadeh, Heidar Sharafi, Mohammad Saeid Rezaee-Zavareh, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Addiction (Abingdon, England)|March 15, 2026
A call for action: Closing the evidence gap in management of stimulant-induced psychosisAnne Bouthillier, Heidar Sharafi, Adam Bisaga, et al.
Systematic Reviews|February 8, 2026
COmprehensive Meta-analysis and meta-regression of Psychiatric disorders in people with Amphetamine-type Stimulant use disorder Study (COMPASS): a protocol for a pilot study, a systematic review and a meta-analysis seriesAnne-Marie Bissonnette, Heidar Sharafi, Florian Alatorre, et al.
Hepatitis Monthly|November 25, 2014
The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control StudyHeidar Sharafi, Seyed Moayed Alavian, Bita Behnava, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 21, 2015
Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013Maryam Keshvari, Heidar Sharafi, Seyed Moayed Alavian, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|December 2, 2016
The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis CMaryam Keshvari, Seyed Moayed Alavian, Bita Behnava, et al.
Hepatitis Monthly|January 27, 2017
Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic ReviewKhashayar Hesamizadeh, Seyed Moayed Alavian, Azar Najafi Tireh Shabankareh, et al.
Pathogens (Basel, Switzerland)|April 28, 2023
Trends in the Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Iranian Patients with Hereditary Bleeding DisordersAzar Gharoonpour, Saeideh Maleki, Hamid Sharifi, et al.
Hepatitis Monthly|April 19, 2014
Interferon alpha-2b therapy in chronic hepatitis deltaMaryam Keshvari, Seyed Moayed Alavian, Heidar Sharafi, et al.
World Journal of Gastroenterology|August 14, 2015
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patientsArghavan Haj-Sheykholeslami, Maryam Keshvari, Heidar Sharafi, et al.
Hepatitis Monthly|June 9, 2016
Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting AntiviralsKhashayar Hesamizadeh, Heidar Sharafi, Mohammad Saeid Rezaee-Zavareh, et al.
Pageof 7